Overview

A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)

Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
A study to assess the safety and efficacy of MK8245 as monotherapy compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.